Sang Won Lee (Sangwon Lee, Sang W Lee)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Virtual Reality

Top Venues

Alimentary pharmacology & therapeutics

Clinical pharmacology and therapeutics

Journal of pain research

This page only lists publications with an associated author ORCID identifier.

Publications

Jae Hyeon Yu, Sang Won Lee, Yoon Jung Kim, Won Young Kim, Min Jung Lee, Yun Kim
Assessing Post-Marketing Requirements for Orphan Drugs: A Cross-Sectional Analysis of FDA and EMA Oversight. Clinical pharmacology and therapeutics (2024)
Jeongsoo Kim, Kwanghoon Jun, Seyong Park, Sang Won Lee
Bibliometric Analysis of Research Articles on Virtual Reality in the Field of Pain Medicine Published from 1993 to 2022. Journal of pain research 16 (2023)
Yun Kim, Shi-Ra Lee, Sang Won Lee
First in human randomised trial of J2H-1702: A novel 11β-hydroxysteroid dehydrogenase type 1 inhibitor for non-alcoholic steatohepatitis treatment. Alimentary pharmacology & therapeutics (2023)
Yun Kim, Inyoung Hwang, Sang Won Lee
Editorial: Liver hypercortisolism as a potential target for MASH treatment-Authors' reply. Alimentary pharmacology & therapeutics 58 (11-12) (2023)
Sojeong Kim, Sang Won Lee, June Young Koh, Donghoon Choi, Minkyu Heo, Jae-Yong Chung, Byung Ha Lee, Se Hwan Yang, Young Chul Sung, Howard Lee, Eui-Cheol Shin, Su-Hyung Park
A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained functions and TCR diversity. Blood advances (2022)